Explore our therapeutic areas
Medical imaging solutions offering quantitative biomarkers, radiology reads and AI-driven digital pathology servicesLearn more
Cholestatic Liver Disease
Drug and biomarker development for cholestatic liver disease, including primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC)Learn more
Integrated analysis of our non-invasive, multi-organ & tumor characterization software, digital pathology and next-generation sequencingLearn more
Autoimmune HepatitisLearn more
A single platform for data
Perspectum’s hardware and software agnostic biomarkers are deployed at scale across our growing network of imaging centers. We specialize in the end-to-end management of imaging studies with our highly trained and specialized imaging staff to deliver centrally analyzed reports.
Centralized analysis is delivered via our secure cloud-based Perspectum Portal platform, providing a single platform to access data and results for your study.
De-risk trial design & reduce timeline to approval
Non-invasive patient satisfaction
Early efficacy safety indication
Long term patient monitoring
Speed up enrollment and reduce dropout
Lower screen fail rate
Enhance trial enrichment
Multi-organ characterization for comprehensive assessment of patient health
Expert central reads of quantitative metrics for:
Liver, kidneys, pancreas, spleen, heart, aorta, biliary tree, colon, body composition, and bone mineral density.
Imaging Technologies include:
MRI, computerised tomography (CT) scans, positron emission tomography (PET) scans, DXA, endoscopy, and digital pathology.